SAGA

Sagaliam Acquisition Corp. (SAGA) | Rumor.io

Sagaliam Acquisition

SAGA

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about SAGA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% 0

Nov 20

The SPAC expiration date for Sagaliam Acquisition Corp. (SAGA) has been stayed, keeping all options alive, including the vote, the closing of the deal with Enzolytics (ENZC), settlement, etc.
Enzolytics shareholders will receive a dividend of ~$44k in SAGA shares by mid-next year, in addition to retaining their ENZC stock, with the potential for a 1:250 share ratio.
A Temporary Restraining Order has been issued by the US District Court for the District of Delaware, preventing Sagaliam Acquisition Corp. from convening a shareholder meeting to extend the deadline date until a preliminary injunction is adjudicated.

Generated by AI

Sentiment

Of the messages about SAGA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100% 0	100% +0.18	96.34% +4.14
Bearish	0%	0% 0	0% -0.18	3.66% -4.14

Sep 18

The completed $450M binding business combination agreement between Sagaliam Acquisition Corp ($SAGA) and ENZC will result in $SAGA trading on the NASDAQ.
ENZC shareholders will receive $SAGA dividends (86:1) and will have exposure to a strong IP portfolio for 20+ diseases with 20-year market exclusivity.
The deal will provide ENZC with $450M to fund trials and license out, positioning $SAGA for billions in revenue and a low float.

Generated by AI

Topics

Of the messages about SAGA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	0%
Announcements	—	—	100%	85.27%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0.16%
Macro	—	—	0%	7.86%
Technical Analysis	—	—	0%	6.71%

Sep 18

Enzolytics ($ENZC) has signed a binding business combination agreement with Sagaliam Acquisition Corp ($SAGA) for the sale of its subsidiaries Biogenysis and Virogentics.
The deal is valued at $450 million and will trade on the NASDAQ.
Enzolytics shareholders will receive $SAGA dividends and will own 90% of the new company, with the ability to fund trials and license out its technology.

Generated by AI

Community

Of the messages about SAGA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	55.7%	13.31%
Newcomers	100%	100%	44.3%	86.69%

Regulars· Sep 18

The $450M binding agreement for the purchase of Enzolytics' subsidiaries by Sagaliam Acquisition Corp. will result in Enzolytics shareholders receiving 86:1 SAGA dividends.
The combined entity will have a strong IP portfolio for 20+ diseases, with a market exclusivity of over 20 years.
The business combination is expected to unlock billions in revenue through licensing deals, with the potential for Regeneron to purchase SAGA, making it a lucrative pure biotech play and cash cow for dividend.

Newcomers· Sep 18

The company Sagaliam Acquisition Corp ($SAGA) has executed a binding business combination agreement with Enzolytics Inc. ($ENZC) to purchase its operating subsidiaries, Biogenysis and Virogentics.
The deal is valued at $450M and will trade on the NASDAQ, with Enzolytics Inc. shareholders set to receive a significant number of $SAGA shares.
The transaction has been viewed as a massive de-risking opportunity for Enzolytics Inc. ($ENZC) shareholders, who can now trade the company's shares with a significantly lower risk profile.

Generated by AI

Also Discussed

Investors talking about SAGA also mention

#	Name	Attention
1	INDT - INDUS Realty Trust, Inc.	——
2	Twist Bioscience CorporationTWST	0%-0.02
3	BioRestorative Therapies, Inc.BRTX	0%0
4	Simulations Plus Inc.SLP	0%0
5	TowneBankTOWN	0%0
6	Safety Shot Inc.SHOT	0%0
7	Main International ETFINTL	0%new
8	HOOK - HOOKIPA Pharma Inc.	——
9	ATCO - Atlas Corp.	——
10	VersaBankVBNK	0%0